ClinicalTrials.gg
Not yet recruitingNCT07296770TPS-SelectUpdated Oct 9, 2026

An Artificial Intelligence Driven Approach to Optimize Patient Selection for a Transitional Pain Service

A Phase 3 interventional study of TPS-Select and Pharmacologic Pain Management in Postsurgical Pain Management, Postsurgical Pain, Chronic and Opioid Use After Surgery, sponsored by University of California, San Francisco. Not yet recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-09.

Sponsored by University of California, San Francisco · Phase 3, Interventional, and Treatment

How we know

Updated Oct 9, 2026Primary completion movedStudy completion moved+3 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 3
Study type
Interventional
Enrollment
474
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 32 studies testing oxycodone in Pain, Postoperative — 5 open to participants now, 7 under way, 1 of them phase 3. Oxycodone · Pain, Postoperative.

Planned enrollment
3rd of 32
474 · median 126
Started
2026
with 2 others
Phase 3
4 of 32
1 open now
Registered
31st of 32
by date

Among the 32 studies testing oxycodone in Pain, Postoperative, this one is the 3rd largest by planned enrollment, is one of 3 that started in 2026, is one of 4 in phase 3, and was the 31st registered.

Pain, Postoperative

5,680 studies on the registry are indexed under Pain, Postoperative; 1,243 are open to participants now.

Browse Pain, Postoperative studies →

Open to participants now

5 of the 32 studies testing oxycodone in Pain, Postoperative are open now, in 3 countries. Recruiting first, the newest first:

By country, each count listing its studies:

All 5 open studies →

About oxycodone

Oxycodone: first FDA approval 1950 (PERCODAN). What it is approved for, and how studies give it, is on its page →

Who these studies take

Of the 678 Pain, Postoperative studies recruiting now, 239 (35%) set no upper age limit and 329 (49%) stop at 75 or younger; 74 take children under 18; 129 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 32 studies testing oxycodone in Pain, Postoperative, or all of them as a file.
02

Study summary

The goal of this clinical trial is to learn whether a pain-management program called a Transitional Pain Service can help prevent long-term pain and reduce opioid needs after surgery in adult surgical patients who may be at higher risk for developing persistent pain. The main questions this trial aims to answer are: 1) Does the Transitional Pain Service help high-risk surgical patients manage pain better after surgery? 2) Can a computer tool (an algorithm) improve screening of patients for long-lasting pain after surgery? The investigators will compare patients who continue with their usual care to patients who receive support from the Transitional Pain Service to see if the program leads to better pain control and lower opioid use. Participants will share information about their pain levels and the pain-relief treatments they are using before and after surgery so researchers can better understand how the program affects recovery. Patients assigned to the Transitional Pain Service will also be offered additional coordinated support before and after their surgery to help optimize their pain control and overall recovery.

03

Conditions studied

  • Postsurgical Pain Management
  • Postsurgical Pain, Chronic
  • Opioid Use After Surgery

Keywords

  • Pain
  • Transitional Pain Service
  • Postsurgical Pain
  • Postoperative Opioid Use
04

Who can participate

The criteria were revised on the registry on Oct 9, 2026. See what changed

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Patients may take part in this study if they:

  • Are 18 years or older
  • Are having a planned (elective) surgery at UCSF
  • Are identified as higher risk for chronic pain after surgery by a computer model
  • Agree to join the study and sign consent

Patients cannot take part if they:

  • Have too much missing information in their medical record (more than 75%)
  • Have a surgery scheduled less than 21 days away
  • Have serious memory or thinking problems that make participation difficult
  • Are in another clinical study that would interfere with this one
  • Do not live in California
  • Choose not to participate or sign consent
  • Have severe depression with suicidal thoughts that requires urgent care
  • Are pregnant or breastfeeding

A patient who has already joined may be removed from the study if they:

  • Cannot complete most of the scheduled follow-up phone calls or pre-surgery recommendations (up to 6 months after discharge)
  • Pass away between the surgery booking date and 6 months after leaving the hospital
  • Become pregnant in the 6 months after discharge

Patients may remain enrolled but their data may not be used in the main study results if they experience:

  • A long-lasting infection after surgery
  • Hardware problems related to their surgery (for example, issues with implanted devices)
  • A major injury or life event that affects their pain levels, such as a significant fall or an emergency surgery
  • Difficulty completing the planned follow-up phone calls up to 6 months after discharge
05

Study design

Phase
Phase 3
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
474 participants (estimated)

Study arms

  • Experimental
    Transitional Pain Service

    Patients assigned to the Transitional Pain Service group will receive extra support before and after surgery to help with pain and recovery. This may include educational videos, meetings with a pain pharmacist for safe medication use and tapering, mental health screening with referrals to supportive resources, and physical therapy. Patients may also be offered pain-relief procedures or treatments such as nerve blocks, injections, imaging, or other outpatient therapies provided by pain specialists. These services are meant to support recovery, and patients may choose how much to participate while remaining in the study even if all activities are not completed.

    Device: TPS-Select · Drug: Pharmacologic Pain Management · Procedure: Interventional Pain Procedures · Behavioral: Psychological Management and Pain Education · Behavioral: Physical Therapy

  • No intervention
    Usual Care

    In this arm, patients will receive usual surgical care. However, patients will still complete the questionnaires to measure their pain, opioid use, and recovery.

Interventions

  • DeviceTPS-Select

    TPS-Select is a computer-based tool that helps the research team identify patients who may be eligible for this study. It uses information that already exists in the medical record at the time a surgery is scheduled to estimate the chance of developing ongoing pain after surgery. This information can include details about the planned surgery, prior medical conditions, past surgeries, and previous use of pain medications. The tool runs automatically and is used only to help the research team decide whom to contact about possible participation in the study. The risk estimate created by this tool is not added to the medical record and is not seen by the patient's care team. Only approved members of the research team can see this information through a secure research system.

  • DrugOxycodoneStudies of OxycodoneOxycodone pageHow we knowJudged by ClinicalTrials.gg, not part of the registry record.

    A pharmacist will meet with patients as part of the Transitional Pain Service before and after surgery. During this visit, the pharmacist will work with patients to create a personalized pain management plan, using the medications stated in this intervention to help safely and effectively control pain. This will guide patients on the proper use of opioid analgesics and non-opioid analgesics, including acetaminophen, non-steroid anti-inflammatory drugs, gabapentinoids, and topical medications to manage surgical pain.

    Also known as: Oxycodone Hydrochloride, Hydrocodone Bitartrate and Acetaminophen, Morphine Sulfate, Methadone Hydrochloride, Buprenorphine, Gabapentin, Duloxetine Hydrochloride, Pregabalin, Amitriptyline Hydrochloride, Nortriptyline Hydrochloride, Hydromorphone, Venlafaxine, Ketamine, Clonidine, Suzetrigine, Baclofen, Tizanidine, Methocarbamol, Cyclobenzaprine, Ketorolac, Celecoxib, Naproxen, Meloxicam, Ibuprofen, Acetaminophen, Alpha-Lipoic Acid

  • ProcedureInterventional Pain Procedures

    If a patient has significant pain after their surgery, the care team may evaluate the patient for additional pain-relief options, such as the interventional pain procedures listed above. Local numbing medication or imaging studies may also be used to ensure the treatment is safe and appropriate. All anesthesiologists on the pain service are specially trained to perform these procedures. Only approved procedures will be offered, along with any imaging needed for evaluation.

    Also known as: Epidural Steroid Injection, Acupuncture, Trigger Point Injection, Peripheral Nerve Block, Joint Injection, Radiofrequency Ablation

  • BehavioralPsychological Management and Pain Education

    Patients will be asked to complete short online pain education modules to help set expectations and prepare for pain after surgery. These materials are available at https://www.transitionalpainservice.ca/learn. Each patient will also be screened for mood-related concerns, including symptoms of depression, using a brief questionnaire. If a patient has significant symptoms of depression, they may be referred to a pain psychologist and, if needed, a UCSF psychiatrist for additional support. These visits may include proven approaches such as cognitive behavioral therapy, acceptance and commitment therapy, and mindfulness-based strategies to help patients manage pain, cope with stress, and improve daily functioning. Patients with milder symptoms may be referred to group-based pain psychology sessions led by a pain psychologist.

  • BehavioralPhysical Therapy

    Patients will be assessed for their physical function and ability to carry out daily activities. If a patient has difficulty with mobility, strength, or endurance, they may be referred to physical or occupational therapy before surgery to help improve overall conditioning. Pre-surgery therapy may include exercises to strengthen the core, arms, and legs, improve balance, and build stamina, as well as an overall fitness assessment. Referrals will only be made if it is safe for the patient to participate, and standard safety checks-such as heart health and fall risk-will be completed beforehand. All therapy will be provided by a licensed physical therapist using established, evidence-based treatment plans.

06

What researchers measure

Primary outcomes

  1. Presence of Chronic Post-Surgical Pain

    This outcome measures how many patients in each group (Standard of Care vs. Transitional Pain Service) have chronic post-surgical pain 90 days after date of surgery. Chronic post-surgical pain refers to worsening pain in a preoperative pain region or the development of pain in a new region.

    Time frame: 90 days after date of surgery

Secondary outcomes

  1. Opioid Use After Surgery

    This measures the amount of opioid medication patients are using after surgery, recorded as morphine milligram equivalents (MMEs). Average MMEs will be compared between groups to see whether the program helps reduce opioid needs.

    Time frame: 30, 90, and 180 days after discharge from hospital

  2. Pain Levels After Surgery

    This outcome looks at patients' reported pain magnitude and pain interference scores over time. The study will compare average pain levels between the two groups to understand how the program affects recovery.

    Time frame: 30, 90, and 180 days after discharge from the hospital

  3. Healthcare Costs

    This measures costs to the hospital related to pain care and recovery after surgery. Average costs will be compared between groups to evaluate whether the Transitional Pain Service may reduce overall costs.

    Time frame: 30, 90, and 180 days after discharge from the hospital

  4. Pain in Surgical Region

    This outcome mreasures patient-reported presence of pain localized to the surgical site.

    Time frame: 30 Days, 90 Days, 180 Days

07

Study locations

1 site
  • UCSF Hospitals
    San Francisco, California 94131, United States
08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be shared with outside researchers because the information collected in this study includes sensitive health details that could pose privacy risks if shared. Although all data are protected and stored securely, sharing IPD outside the study team may increase the chance of re-identification. To protect patient privacy, only summarized results that do not identify any individual will be shared publicly.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Oct 2026; primary completion for Dec 2028, 26 months later.

Of 124 non-industry phase 3 interventional studies under Pain, Postoperative, half reached primary completion within 20 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 40. This study's planned 26 months is above that.

Counting every sponsor, half of 167 studies reached it within 17 months; a quarter within 8 and three quarters within 30.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 9, 2026: primary completion Dec 2027 → Dec 2028 and completion Jul 2028 → Dec 2029.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Dec 18, 2025
First posted
Dec 22, 2025
StartEst.
Oct 1, 2026
Primary completionEst.
Dec 1, 2028was Dec 2027
CompletionEst.
Dec 1, 2029was Jul 2028
Last update
Oct 9, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Primary completion
Dec 1, 2027→Dec 1, 2028
Oct 9, 2026
Study completion
Jul 1, 2028→Dec 1, 2029
Oct 9, 2026
Enrollment
126→474
Oct 9, 2026
Eligibility
1 criterion edited
What changed in the criteria
  • EditedHave a surgery scheduled less than 1 month21 days away
Oct 9, 2026
Primary outcomes
1 edited
What changed in the outcomes
  • EditedProportionPresence of Patients With Chronic Post-Surgical PainTime frame: 90 days after date of surgery
Oct 9, 2026
Secondary outcomes
3 time frame changed, 1 added, 1 description edited
What changed in the outcomes
  • AddedPain in Surgical RegionTime frame: 30 Days, 90 Days, 180 Days
  • Time frameOpioid Use After Surgery30, 60, and 90 days after discharge from hospital → 30, 90, and 180 days after discharge from hospital
  • Time framePain Levels After Surgery30, 60, and 90 days after discharge from the hospital → 30, 90, and 180 days after discharge from the hospital
  • Time frameHealthcare Costs30, 60, and 90 days after discharge from the hospital → 30, 90, and 180 days after discharge from the hospital
  • DescriptionPain Levels After Surgery: how it is measured was reworded
Oct 9, 2026
Show all 1 update
  1. Oct 9, 2026
    Primary completion Dec 1, 2027→Dec 1, 2028
    Study completion Jul 1, 2028→Dec 1, 2029
    Enrollment 126→474
    Eligibility 1 criterion edited
    What changed in the criteria
    • EditedHave a surgery scheduled less than 1 month21 days away
    Primary outcomes 1 edited
    What changed in the outcomes
    • EditedProportionPresence of Patients With Chronic Post-Surgical PainTime frame: 90 days after date of surgery
    Secondary outcomes 3 time frame changed, 1 added, 1 description edited
    What changed in the outcomes
    • AddedPain in Surgical RegionTime frame: 30 Days, 90 Days, 180 Days
    • Time frameOpioid Use After Surgery30, 60, and 90 days after discharge from hospital → 30, 90, and 180 days after discharge from hospital
    • Time framePain Levels After Surgery30, 60, and 90 days after discharge from the hospital → 30, 90, and 180 days after discharge from the hospital
    • Time frameHealthcare Costs30, 60, and 90 days after discharge from the hospital → 30, 90, and 180 days after discharge from the hospital
    • DescriptionPain Levels After Surgery: how it is measured was reworded
    + 4 other changes: index terms, verification date, design details and arm descriptions

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07296770
Responsible party
Sponsor
First posted
Dec 22, 2025
Start date
Oct 1, 2026 (estimated)
Primary completion
Dec 1, 2028 (estimated)
Completion
Dec 1, 2029 (estimated)
Last update
Oct 9, 2026

Study contacts

Akash Shanmugam, BS
Contact
akash.shanmugam@ucsf.edu
408-242-3095
Madeline Holt, BS
Contact
madeline.holt@ucsf.edu
978-317-9071
Andrew Bishara, MD
principal investigator · UCSF Department of Anesthesia

Oversight

Data monitoring committee
Yes
FDA-regulated drug
Yes
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Oxycodone

Start the discussion